NCT06797505View on ClinicalTrials.gov

A Bioequivalence Study of Two Different PEG-rhGH Preparations

PHASE1CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

February 10, 2025

Primary Completion Date

April 29, 2025

Study Completion Date

May 30, 2025

Conditions
Pediatric Growth Hormone Deficiency (PGHD)
Interventions
DRUG

PEG-rhGH with new preparation (T)

A single subcutaneous injection of PEG-rhGH with new preparation

DRUG

PEG-rhGH with present preparation (T)

A single subcutaneous injection of PEG-rhGH with present preparation

Trial Locations (1)

610000

Chengdu Xinhua Hospital, Chengdu

All Listed Sponsors
lead

Changchun GeneScience Pharmaceutical Co., Ltd.

INDUSTRY

NCT06797505 - A Bioequivalence Study of Two Different PEG-rhGH Preparations | Biotech Hunter | Biotech Hunter